Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.1063
H.R.1063: Drug Competition Act of 2001
About This Bill
- This bill was introduced in the 107th Congress
- This bill is primarily about law
- Introduced March 15, 2001
- Latest Major Action March 22, 2001
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Summary
Drug Competition Act of 2001 - Requires brand name drug manufacturers and generic drug manufacturers to notify the Federal Trade Commission and the Attorney General of agreements regarding the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
|
|
Referred to House Energy and Commerce
|
|
|
Referred to House Judiciary
|
|
|
Referred to the Subcommittee on Health.
|
|
| March 15, 2001 |
Introduced in the House by Robert E. Andrews (D-N.J.) |